Neighbourly Pharmacy Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Neighbourly Pharmacy yıllık ortalama 23.9% oranında kazançlarını artırırken, Consumer Retailing sektöründe kazançlar growing at 6.5% annual. Gelirler yılda ortalama 35.3% oranında büyüyor .

Anahtar bilgiler

23.9%

Kazanç büyüme oranı

70.0%

EPS büyüme oranı

Consumer Retailing Sektör Büyümesi	10.3%
Gelir büyüme oranı	35.3%
Özkaynak getirisi	-5.5%
Net Marj	-3.7%
Son Kazanç Güncellemesi	30 Dec 2023

Yakın geçmiş performans güncellemeleri

Recent updates

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Aug 15

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Mar 22

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Dec 09

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

Aug 10

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Mar 21

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Feb 27

Gelir ve Gider Dağılımı

Neighbourly Pharmacy nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSX:NBLY Gelir, gider ve kazançlar (CAD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Dec 23	875	-33	264
09 Sep 23	856	-37	256
17 Jun 23	832	-27	246
25 Mar 23	749	-15	218
31 Dec 22	671	-2	192
10 Sep 22	545	6	153
18 Jun 22	457	3	127
26 Mar 22	428	-73	117
01 Jan 22	398	-52	108
11 Sep 21	369	-163	98
19 Jun 21	337	-163	88
27 Mar 21	306	-91	80
02 Jan 21	276	-129	73
28 Mar 20	187	-23	51
30 Mar 19	150	-23	48
31 Mar 18	93	-18	28

Kaliteli Kazançlar: NBLY şu anda kârlı değil.

Büyüyen Kar Marjı: NBLY şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NBLY kârlı değildir, ancak son 5 yılda zararlarını yılda 23.9% oranında azaltmıştır.

Büyüme Hızlandırma: NBLY 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: NBLY kârlı olmadığından, geçmiş yıl kazanç büyümesinin Consumer Retailing sektörüyle ( -11.7% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: NBLY hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -5.48% ) sahiptir.

Neighbourly Pharmacy Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024

Neighbourly Pharmacy Inc. to Report Q2, 2024 Results on Oct 24, 2023

First quarter 2024 earnings released: CA$0.27 loss per share (vs CA$0.029 loss in 1Q 2023)

Neighbourly Pharmacy Inc. to Report Q1, 2024 Results on Aug 01, 2023

Full year 2023 earnings released: CA$0.37 loss per share (vs CA$2.57 loss in FY 2022)

Recent updates

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024

Upcoming dividend of CA$0.045 per share at 1.0% yield

Now 22% undervalued

Neighbourly Pharmacy Inc. to Report Q2, 2024 Results on Oct 24, 2023

PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.

New major risk - Share price stability

Upcoming dividend of CA$0.045 per share at 1.1% yield

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Forecast breakeven date pushed back to 2025

First quarter 2024 earnings released: CA$0.27 loss per share (vs CA$0.029 loss in 1Q 2023)

Neighbourly Pharmacy Inc. to Report Q1, 2024 Results on Aug 01, 2023

Upcoming dividend of CA$0.045 per share at 1.1% yield

Independent Chairman of the Board recently bought CA$599k worth of stock

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 3, 2023

Full year 2023 earnings released: CA$0.37 loss per share (vs CA$2.57 loss in FY 2022)

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into a binding agreement to acquire Seven Pharmacies in Western Canada.

Neighbourly Pharmacy Inc. (TSX:NBLY) has entered into a binding agreement to acquire Three pharmacies in Ontario.

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 01, 2023

Neighbourly Pharmacy Inc. to Report Q4, 2023 Results on Jun 08, 2023

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Upcoming dividend of CA$0.045 per share at 0.7% yield

CEO & Director recently bought CA$272k worth of stock

Forecast breakeven date pushed back to 2024

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on April 11, 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 42%

Neighbourly Pharmacy Inc. to Report Q3, 2023 Results on Feb 14, 2023

Neighbourly Pharmacy Inc. Announces CEO Changes

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Cloverdale Pharmacy Ltd. and Steveston Health Centre Ltd. from CloudMD Software & Services Inc. (TSXV:DOC)

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on December 20, 2022

Consensus forecasts updated

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired Assets of a Retail Pharmacy Located in Manitoba.

Neighbourly Pharmacy Inc. (TSX:NBLY) enter into a binding agreement to acquire Two Community Pharmacies Located in British Columbia.

Consensus forecasts updated

Now 21% undervalued after recent price drop

Neighbourly Pharmacy Inc. Appoints Billy Wong as CFO to Succeed Terri Smyth

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

First quarter 2023 earnings: EPS misses analyst expectations

Neighbourly Pharmacy Inc. Declares Dividend on Common Share for the First Quarter Ended June 18, 2022, Payable on September 27, 2022

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Rubicon Pharmacies Canada Inc.

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to CA$33.44

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 18, 2022

Neighbourly Pharmacy Inc. to Report Q1, 2023 Results on Aug 02, 2022

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 02, 2022

Neighbourly Pharmacy Inc. to Report Q4, 2022 Results on Jun 23, 2022

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. announced that it has received CAD 138.163875 million in funding from PCP GP, L.P.

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Upcoming dividend of CA$0.045 per share

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into an agreement to acquire one additional pharmacy in Canada.

Consensus forecasts updated

Upcoming dividend of CA$0.045 per share

Second quarter 2022 earnings released: CA$0.11 loss per share (vs CA$24.48 loss in 2Q 2021)

Upcoming dividend of CA$0.045 per share

Forecast breakeven pushed back to 2023